Sector Gamma ASA as of Sept. 30, 2011
Portfolio Holdings for Sector Gamma ASA
Sector Gamma ASA holds 27 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 10.9 | $37M | 996k | 36.97 | |
| Bristol Myers Squibb (BMY) | 8.6 | $29M | 926k | 31.38 | |
| Abbott Laboratories (ABT) | 7.9 | $27M | 517k | 51.14 | |
| Medtronic | 6.2 | $21M | 627k | 33.24 | |
| Onyx Pharmaceuticals | 5.7 | $19M | 639k | 30.01 | |
| Forest Laboratories | 5.5 | $19M | 606k | 30.79 | |
| WellPoint | 5.4 | $18M | 280k | 65.28 | |
| Cardinal Health (CAH) | 4.7 | $16M | 376k | 41.88 | |
| Merck & Co (MRK) | 4.7 | $16M | 481k | 32.71 | |
| Cubist Pharmaceuticals | 4.5 | $15M | 427k | 35.32 | |
| Quest Diagnostics Incorporated (DGX) | 3.9 | $13M | 267k | 49.36 | |
| Life Technologies | 3.8 | $13M | 336k | 38.43 | |
| CVS Caremark Corporation (CVS) | 3.7 | $12M | 369k | 33.58 | |
| Zimmer Holdings (ZBH) | 3.5 | $12M | 223k | 53.50 | |
| St. Jude Medical | 3.5 | $12M | 321k | 36.19 | |
| Thermo Fisher Scientific (TMO) | 2.4 | $8.1M | 160k | 50.64 | |
| Watson Pharmaceuticals | 2.3 | $7.8M | 115k | 68.25 | |
| ResMed (RMD) | 2.2 | $7.4M | 256k | 28.79 | |
| Boston Scientific Corporation (BSX) | 2.0 | $6.6M | 1.1M | 5.91 | |
| Covidien | 1.9 | $6.2M | 141k | 44.10 | |
| Tenet Healthcare Corporation | 1.7 | $5.6M | 1.4M | 4.13 | |
| Hologic (HOLX) | 1.3 | $4.5M | 297k | 15.21 | |
| Impax Laboratories | 1.2 | $3.9M | 218k | 17.91 | |
| Amylin Pharmaceuticals | 0.9 | $3.1M | 335k | 9.23 | |
| United Therapeutics Corporation (UTHR) | 0.7 | $2.4M | 65k | 37.49 | |
| Optimer Pharmaceuticals | 0.6 | $2.1M | 154k | 13.84 | |
| Momenta Pharmaceuticals | 0.3 | $992k | 86k | 11.50 |
